On-Demand: EU Healthcare and Pharmaceutical Policy in 2023: What You Need to Know
Watch the webinar recording to hear from EU Issue Tracker analysts and industry experts discuss the latest policy developments creating opportunities for businesses operating in pharmaceuticals, medical devices, and healthcare.
From the ongoing revision of the EU pharmaceutical legislation package and addressing critical supply issues to the impact of the recent Medical Device Regulation transition period extension, the challenges in EU healthcare and pharmaceutical policy are ever-evolving. Plus, with the implementation of critical files, such as the European Health Data Space (EHDS) and the Substances of Human Origin (SoHo) regulation, it's vital for organizations in this market to stay up-to-date with the latest policy and regulatory developments.
In this webinar, learn more about the latest updates in legislation and regulation that are shaping the future of healthcare, pharmaceutical, and medical device industries in Europe to help you navigate the next steps in this policy landscape.
The ongoing revision of EU pharmaceutical legislation
Tackling critical supply issues in pharmaceuticals and medical devices
The impact of the Medical Device Regulation transition period extension
Proposed and upcoming critical files you should be monitoring
The future of EU healthcare policy in 2023 and beyond
Adrien Samson, healthcare policy & public affairs senior manager, EuropaBio
Jelle Verheij, policy analyst - health and pharmaceuticals policy, EU Issue Tracker
Moderator: Geraint Edwards, managing director of FiscalNote Brussels